Related by context. All words. (Click for frequent words.) 85 Sign License Agreement 85 Announce License Agreement 84 Signs License Agreement 83 Announces Licensing Agreement 82 Announce Merger Agreement 82 Announce Collaboration Agreement 82 Announces License Agreement 82 Sign Licensing Agreement 82 Completes Merger With 81 Settle Patent Dispute 80 Expands Portfolio 80 Q3 Loss Narrows 80 Begins Shipment 80 Q1 Loss Narrows 80 Q2 Loss Narrows 80 Files Shelf Registration Statement 80 Signs Licensing Agreement 79 Shareholders Approve Acquisition 79 Q3 Loss Widens 79 Licenses Novel 79 Jumps Higher 79 Welcomes Analyst Initiation 79 Successfully Completes Acquisition 79 Successfully Completes Tender Offer 79 Collaborates With 79 Settles Patent Dispute 79 Initiates Enrollment 79 Sinks Lower 79 Finalizes Acquisition 79 Extends Collaboration 79 Announces FDA Clearance 79 Files IND 79 Submits Application 79 Q4 Loss Narrows 79 Q2 Loss Widens 79 Introduces Innovative 79 Files Patent Application 79 Settle Patent Litigation 79 Unveils Revolutionary 78 Earnings Postmortem 78 Unveils Innovative 78 Amends Agreement 78 Submits Biologics License Application 78 Receives Favorable 78 Enters Into Licensing Agreement 78 Introduces Enhanced 78 Finalizes Purchase 78 Announces Additions 78 Enters Oversold Territory 78 Guides Inline 78 Completes Patient Enrollment 78 Announce Exclusive 78 Introduces Next Generation 78 Strengthens Position 78 Thewallstreetleader.com Profiles 78 Introduces Breakthrough 78 Announces Favorable 78 Receives Approvable Letter 77 Launches Groundbreaking 77 AUDIO PROVIDED BY 77 Q1 Loss Widens 77 Announce Collaboration 77 Achieves ISO #:# Certification [002] 77 Inks Licensing Deal 77 Extend Collaboration 77 Commercializes 77 Receives Clearance 77 Introduces Novel 77 Gets FDA Clearance 77 Unveils Latest 77 Shareholders Approve Sale 77 Launches Unique 77 Stockholders Approve Acquisition 77 Receives Patent 77 Settles Patent Litigation 77 Announces Immediate Availability 77 Confirms Commitment 77 Licenses Patents 77 Stockholders Approve Merger 77 Announces Stockholder Approval 77 Acquires Exclusive 77 Streamlines Operations 77 CFO Exercises Options 77 Bearish MACD 77 Q2 Adj 77 Q1 Adj 77 Showcases Innovative 77 Announces Sponsorship 77 Buys Majority Stake 76 Movers Roundup 76 Announce Availability 76 Completes Tender Offer 76 Announce Licensing 76 Expand Relationship 76 Completes Merger 76 Restructures Operations 76 Closes Acquisition Of 76 Releases Next Generation 76 Launches Next Generation 76 Q4 Loss Widens 76 Initiates Clinical Trial 76 Director Exercises Options 76 TheWallStreetLeader.com Profiles 76 Extend Partnership 76 Enters Into Exclusive 76 Launches Innovative 76 Successfully Concludes 76 Settles Litigation 76 Completes Buyout 76 Exploring Strategic Alternatives 76 FY# Loss Widens 76 SVP Exercises Options 76 Expand Collaboration 76 Introduces Revolutionary 76 Announces Divestiture 76 Initiates Phase II 76 Forges Partnership 76 Completes Acquisitions 76 Therapeutic Competitors Companies 76 Q3 Profit Soars 76 Attracting Bullish Investors 76 Announces Organizational Changes 76 Delivers Next Generation 76 Finalizes Sale 76 Successfully Closes 76 Q3 Adj 76 Announces Formation 76 Begins Shipping 76 Signs Merger Agreement 76 Renews Agreement 76 Unveils Next Generation 76 Submits NDA 76 Receives Tentative Approval 76 BioSante Pharmaceuticals Announces 76 Q1 Profit Surges 76 Announces Early Termination 76 Announces Definitive Agreement 76 Settles Patent Suit 76 Taglich Brothers Initiates Coverage 76 CEO Exercises Options 76 Receives Milestone Payment 76 DayTradersDigest.com Profiles 76 Completes Divestiture 76 Obtains Approval 76 Settle Litigation 76 Subsidiary Enters 75 Initiates Dosing 75 VP Exercises Options 75 Q4 Profit Surges 75 NewsBite Downgrade Puts Pressure 75 Announce Expanded 75 Introduces Expanded 75 Q2 Profit Soars 75 Awarded Patent 75 Debuts Next Generation 75 Awarded Patents 75 SWOT Analysis Aarkstore Enterprise 75 Net Loss Widens 75 Post Earnings Checkup 75 Explore Strategic Alternatives 75 Restructures Debt 75 Introduces Unique 75 Spins Off 75 Closes Previously Announced 75 Announce Definitive Agreement 75 Aquires 75 Celebrates Tenth Anniversary 75 Announces Discontinuation 75 Enters Into License Agreement 75 Unveils Breakthrough 75 Deliver Presentation 75 Enters Exclusive 75 FDA Clears 75 Unveils Groundbreaking 75 Unveils Newest 75 Terminates Agreement 75 Discontinues 75 FY# Loss Narrows 75 Completes Previously Announced 75 Shareholders Approve Merger Agreement 75 Ups Guidance 75 Terminates Contract 75 COO Exercises Options 75 Launches Redesigned Website 75 Jointly Announce 75 Enters Strategic 75 Enrolls First 75 Receives Favorable Ruling 75 Completes Recapitalization 75 Files Patent 75 Develops Breakthrough 75 Announces Termination 75 Announces Tentative Approval 75 Acquires Remaining Interest 75 Q1 Profit Decreases 75 Unveils Expanded 75 Achieves Milestone 75 Secures Financing 75 Acquires Controlling Interest 75 Completes Enrollment 75 Completes Expansion 75 Reach Settlement Agreement 75 Q4 Profit Plunges 75 Receives FDA Clearance 75 Bearish Pressure Building 75 Receives Orphan Drug Designation 75 Expands Relationship With 75 Announces Effective Date 74 Amend Merger Agreement 74 PROFILE CO 74 IG HCR ;) CO 74 Bearish Speculation 74 Posts Narrower Loss 74 Provides Shareholder 74 EVP Exercises Options 74 Presents Positive 74 Submits IND 74 Voluntarily Withdraw 74 Appoints Experienced 74 Outlines Strategy 74 Obtains License 74 Terminate Merger Agreement 74 Begins Dosing 74 Appoints Seasoned 74 Reveals Positive 74 MONSTERSTOX.COM Monsterstox.com 74 Develops Innovative 74 Approaching Resistance 74 Announces Initiation 74 Upside Looming 74 Q4 Profit Climbs 74 Signs Licensing 74 R MSCRAMM 74 Daytradersdigest.com Profiles 74 Introduces Groundbreaking 74 Q2 Profit Surges 74 Completes Financing 74 CybeRelease Decliners 74 Daytradersdigest.com 74 Completes Restructuring 74 Strengthens Its 74 Showcases Latest 74 Narrows Guidance 74 Initiates Clinical 74 Introduces Powerful 74 Enters Into Strategic 74 Completes Asset 74 Develop Next Generation 74 Broadens Its 74 Expands Commitment 74 Net Loss Narrows 74 Announce Settlement 74 Announces Rebranding 74 Posts Strong 74 Other OTC MNDP 74 Announces Postponement 74 Voluntarily Withdraws 74 Reports Positive 74 Extends Commitment 74 Introduces Affordable 74 Provides Update Regarding 74 Consummates 74 Announce Joint Venture 74 Lowers Guidance 74 Revitalizes 74 Retains Investor Relations 74 Announces Expanded 74 Officially Launches 74 Announces Recapitalization 74 Updates Guidance 74 Enters Agreement 74 Reports Double Digit 74 Releases Enhanced 74 Earnings Scorecard 74 Strengthens Balance Sheet 74 Posts Wider 4Q Loss 74 Regains Compliance With 74 Reports Receipt 74 Board Authorizes 74 Introduce Next Generation 74 Develop Novel 74 Receives Unsolicited 74 Announces Shareholder Approval 74 Posts Wider 74 Completes Purchase Of 74 Inc. OTCBB MNDP 74 Holds Annual Meeting 74 Achieves Significant 74 Secures Patent 74 Unwraps 74 Beats Estimates Analyst Blog 74 AllPennyStocks.com Spotlights 74 Reacquires 74 Strengthens Commitment 73 Acquirer Company 73 CRWESelect CRWESelect.com Highlights 73 Retains CCG Investor Relations 73 Extends Tender Offer 73 Announces Enhancements 73 Receives NASDAQ 73 Announces Signing 73 Announces Adjournment 73 Mutually Agree 73 Celebrates Successful 73 Announce Early Termination 73 Files Shelf Registration 73 Concludes Successful 73 Adopts Stockholder Rights 73 Announce Launch 73 Expands Availability 73 Posts Wider Loss 73 Therapeutic Competitors Report 73 Stockholders Approve Merger Agreement 73 Q3 Profit Surges 73 Announce Breakthrough 73 Stays Neutral 73 Announces Successful Completion 73 Anounces 73 Announce Initiation 73 Announce Formation 73 Makes Unsolicited Bid 73 Initiates Voluntary Recall 73 Reversal Soon 73 Reschedules Fourth Quarter 73 Rated Speculative Buy 73 Calls Purchased 73 Regains Compliance 73 Obtains Exclusive License 73 Q3 Profit Decreases 73 Inc. Nasdaq OXGN 73 Broadens Scope 73 Inks Distribution 73 Q4 Profit Soars 73 PRODUCT SOURCE 73 Launches Enhanced 73 Takes Majority Stake 73 Finalizes Agreement 73 Guides Below 73 Receives CE Marking 73 Endures Analyst Downgrade 73 Closes Acquisition 73 Enters Joint Venture 73 Showcases Next Generation 73 Wins Patent Infringement 73 CONFERENCE CALLS SOURCE 73 Announces Stock Buyback 73 Acquires Assets 73 Inks License 73 Regains Full 73 Completes Successful 73 Shareholders Approve Merger 73 Complete Merger 73 Settles Dispute 73 Completes Transition 73 Adopts Shareholder Rights 73 Announces Issuance 73 Completes Transaction 73 Releases Latest 73 Delivers Solid 73 Remains Neutral 73 Further Strengthens 73 Provides Preliminary 73 Announces Revised 73 Unveils Upgraded 73 Inks Deal With 73 Announces Presentation 73 Sign Definitive Agreement 73 Withdraws Proposal 73 Announces Consummation 73 Completes Reorganization 73 Inc. LATEST NEWS 73 Bullish Technical Alert 73 Files Annual Report 73 Withdraws Application 73 Achieves Positive 73 Engages CHF Investor Relations 73 Completes Reverse Merger 73 Zacks Earnings Preview 73 Posts 4Q 73 Reports Narrower 73 Q1 Profit Plunges 73 Inc.today announced 73 Posts 2Q 73 Completes Refinancing 73 Reports Profitable 73 Narrows Loss 73 Announces Departure 73 Announces Dismissal 73 Provides Guidance 73 Beats Raises Guidance 73 Demonstrates Next Generation 73 Presents Preclinical Data 73 Provides Updated 72 Ventures Invests 72 Delivers Strong 72 Seeks Approval 72 Spins Out 72 Conference Call TRANSCRIPT 72 3Q Loss Widens 72 Extends Expiration Date 72 Announce Agreement 72 Acquire Assets 72 Restate Financials 72 Completes Purchase 72 Engages Investor Relations 72 Extends Relationship 72 Achieves Record Sales 72 Observation Features 72 Scoops Up 72 Reaffirms Outlook 72 Explores Strategic Alternatives 72 Significantly Expands 72 Q1 Profit Rises 72 Enters Into Definitive 72 Sets Quarterly Dividend 72 Terminates Merger Agreement 72 Announce Completion 72 Bullish Average Crossover 72 Commences Trading 72 Announces Preliminary 72 Enter Into 72 Moving Average Crossover Alert 72 TSX Delisting Review 72 Receives Subpoena 72 Signs Purchase Agreement 72 CEO Discusses F#Q# [001] 72 Announces Stock Repurchase 72 Host Fourth Quarter 72 Exec Exercises Options 72 Announce Commencement 72 Enters Into Definitive Agreement 72 Sign Definitive Merger 72 Wins Approval 72 Continues Aggressive 72 Dramatically Expands 72 Commences Cash 72 Joins OTCQX 72 Formalizes 72 Buy Privately Held 72 Q1 Profit Declines 72 Winning Streak Continues 72 Celebrates Opening 72 Monetizes 72 Posts 1Q Profit 72 Inks Pact 72 Signs Agreements 72 Unveils Enhanced 72 Expands Capabilities 72 Receives Orphan Drug 72 Receive Milestone Payment 72 Revises Guidance 72 Announce Receipt 72 Inc Therapeutic Competitors 72 Puts Purchased 72 Regains NASDAQ 72 Webcast Annual Meeting 72 Q4 Profit Decreases 72 Premarket Roundup 72 Obtains Exclusive Rights 72 platform HDL Mimetic 72 Stockholders Approve 72 Announces Job Cuts 72 Demonstrates Significant 72 Q2 Profit Rises 72 Q4 Profit Declines 72 Forges Strategic 72 Q2 Profit Declines 72 Submits Response 72 Terminate Agreement 72 Receives Notice Regarding 72 Makes Bearish 72 Retains Leading 72 Board Unanimously Rejects 72 Extend Relationship 72 Receives Notice From 72 Ships #th 72 Releases Third Quarter 72 Completes Initial 72 Receives Conditional 72 Extends Relationship With 72 Sign Reseller Agreement 72 Q3 Profit Rises 72 Announce Strategic 72 Unveils Powerful 72 Patent Issued 72 Finalizes Purchase Of 72 Announces Reseller Agreement 72 Canaccord Genuity Maintains Hold 72 Announces Underwriters Exercise 72 Named Exclusive Distributor 72 Announces Timing 72 Hold Fourth Quarter 72 Closes Sale 72 Completes Acquisition 72 Doubles Size 72 Achieves Breakthrough 72 Ramps Up Production 72 Wolf Haldenstein Investigating 72 Announces Publication 72 Bullish Speculation 72 Changes Ticker Symbol 72 * vwd PRN 72 Canaccord Genuity Reiterates Buy 72 Narrows 4Q Loss 72 Initiates Phase III 72 Announces Share Repurchase 72 Strengthens Leadership 72 Review Strategic Alternatives 72 Completes Integration 72 Announces Upcoming 72 Gobbles Up 72 Ink Deal 72 Nasdaq XTLB 72 Formally Launches 72 NASDAQ. 72 Receives Clearance From 72 Launches Expanded 72 Announces Addition 72 1Q Profit Triples 72 Jointly Offer 72 Expands Offerings 72 Named Fastest Growing 72 Assets Acquirer Company 72 Posts Solid 72 Files Patents 72 INDICATED LOWER 72 Receives Certification 72 Bearish Average Crossover 72 Expands Scope 72 Files Voluntary 72 Completes Dosing 72 Starts Shipping 72 Announces Poster Presentations 72 Puts Sold 72 Delivers Breakthrough 72 Jointly Develop 72 Inc. Attracting Bullish 72 Boosts Buyback 72 Jointly Launch 72 Cites Positive 71 Updates Fourth Quarter 71 Posts Narrower 71 Secures Funding 71 Gets Bearish Confirmation 71 Therapeutic Competitors companiesandmarkets.com adEgemonye 71 Ltd. Acquirer 71 Closes Merger 71 2Q Loss Widens 71 Completes Sale 71 Achieves Certification 71 Finalize Agreement 71 BayStreet.ca Research Alert 71 Shares Plunged What 71 Executes Agreement 71 Exercises Option 71 Demonstrates Latest 71 Gets Clearance 71 Signs Exclusive 71 Bullish Engulfing Pattern 71 Becomes Largest 71 Plans Job Cuts 71 Enters Into Agreement 71 Trims Loss 71 Q4 Profit Rises 71 Secures Long Term 71 1Q Loss Widens 71 Reports Significantly Improved 71 Achieves ISO # 71 Distribution Pact 71 Receives Notification 71 Announces Cancellation 71 Concludes Acquisition 71 Q3 Profit Declines 71 CRWEWallstreet.com Stock Report 71 Q1 Profit Soars 71 Receives Stockholder Approval 71 Announces Reverse Split 71 F#Q# Qtr End 71 Broadens Product 71 Withdraws Offer 71 Posts 4Q Profit 71 Expects Higher 71 Rebrands 71 Signs Reseller Agreement 71 Accepted Into 71 Signs Distribution 71 4Q Profit Surges 71 Present Preclinical Data 71 Signs Lease 71 Novartis Novo Nordisk 71 CFO Resigns 71 Takes Stake 71 4Q Loss Widens 71 Furthers 71 Reports Preclinical Data 71 Attains Gold Certified Partner 71 Regains Nasdaq 71 Genentech sanofi aventis 71 Renews Partnership 71 Announces Intent 71 Fastmoneytalk.com 71 Bullish Engulfing Formed 71 Awarded Multi 71 Unveil Latest 71 Evaluate Strategic Alternatives 71 Schedules Fourth Quarter 71 Shares Plummet 71 Sets Second Quarter 71 Subsidiary Acquires 71 Continues Commitment 71 Fortifies 71 Launches Breakthrough 71 Achieves Record 71 Surpasses Estimates 71 Boosts Guidance 71 Settle Patent 71 Q4 Profit Jumps 71 Inks Deals 71 Announces Commencement 71 Demonstrates Interoperability 71 Sanofi Aventis Schering Plough 71 Increases Ownership 71 Identifies Key 71 Purchases Moore Microprocessor 71 Announces Definitive Merger 71 Updates Shareholders 71 TM Aganocide 71 Licensing Pact 71 Stock Downgraded 71 Q3 Profit Drops 71 Attains 71 Files Preliminary Prospectus 71 Celebrates Decade 71 MARKETING AGREEMENTS PRODUCT SOURCE 71 4Q Profit Doubles 71 Range Tightening 71 Introduces Newest 71 Completes Sale Of 71 #.#.# Meldung [001] 71 Receives Authorization 71 Announces Launch 71 INDICATED HIGHER 71 Becomes Exclusive 71 Delays Filing 71 CONFERENCE CALLS EARNINGS SOURCE 71 Acquires Majority 71 Earnings Rise Sharply 71 Receives Commitment 71 Sets Dates 71 Nasdaq ANPI 71 Enters Into Joint Venture 71 Secures Additional 71 FDA Okays 71 Clears Path 71 Reduces Debt 71 Delivers Innovative 71 Reveals Receipt 71 Renews Relationship 71 Provides Clarification 71 Ink Pact 71 Exec Joins 71 ADDING MULTIMEDIA 71 Establishes Strategic 71 Delivers Enhanced 71 Releases Latest Version 71 Dividend Yield Outperforms 71 Extends Reach 71 Annouces 71 Files Definitive Proxy 71 Directors Elects 71 Amends Terms 71 Schaeffer Sentiment Snapshot 71 Expands Internationally 71 Candlesticks Bearish Engulfing 71 Sharpens Focus 71 Receives Positive 71 Licensing Deal 71 Novartis Organon 71 MARKETING AGREEMENTS SOURCE 71 Increases Size 71 Closes Buyout 71 Files Registration Statement 71 Completes Spin Off 71 1Q Profit Declines 71 Unveil Next Generation 70 Sells Itself 70 Shares Popped What 70 Receives SFDA Approval 70 Inc. F#Q# Qtr 70 Analyst Actions 70 Receives Approval From 70 Identifies Potential 70 narrows Quick Facts 70 Trims Outlook 70 Submits Supplemental 70 Accelerates Expansion 70 Q2 Profit Slips 70 Options Trader Alert 70 Guides Above 70 Revises Fourth Quarter 70 Initiates Clinical Trials 70 Enters Into Long Term 70 Reconfirms 70 Sets Record Date 70 Completes Debt Refinancing 70 Enhances User Experience 70 Stock Soars 70 Q2 Profit Plunges 70 Renews Sponsorship 70 Hold Third Quarter 70 Delivers Unparalleled 70 Announces Spin Off 70 Complies With 70 Launches Redesigned Web 70 Releases Second Quarter 70 Launches Generic Version 70 Announces Keynote Speakers 70 Declares Regular Cash Dividend 70 Announce Merger 70 Earns Milestone Payment 70 TheNewsWire Gainers 70 Expands Deployment 70 Files Patent Infringement 70 Boosts Productivity 70 Reaches Settlement Agreement 70 Earnings Surge 70 Files Patent Infringement Lawsuit 70 Demonstrate Latest 70 Inks Licensing Agreement 70 Announces Appointments 70 Updates Status 70 DARA logo 70 Restructures 70 IIROC Halt 70 2Q Profit Doubles 70 Unsolicited Proposal From 70 Amends Credit 70 Successfully Launches 70 Ups Bid 70 Slashes Guidance 70 Slashes Price 70 Reaffirms Guidance 70 Extends Leadership 70 Obtains Exclusive 70 Significantly Increases 70 Schedules Webcast 70 Hires Lobbyist 70 Settles Patent Lawsuit 70 Delivers Comprehensive 70 Subsidiary Enters Into 70 Wins Summary Judgment 70 Bulks Up 70 3Q Loss Narrows 70 Relaunches Website 70 Sells Shares 70 Shares Soar 70 Finalizes Merger 70 Receives Notice 70 Reports Wider Loss 70 Extends Capabilities 70 Announce Groundbreaking 70 Boosts Quarterly Dividend 70 Confirms Receipt 70 Begins Tender Offer 70 Rejects Takeover Bid 70 Extends Maturity 70 Declares Qtr 70 Completes Rollout 70 Announce Expiration 70 Declares Quarterly Dividends 70 Commences Phase 70 2Q Profit Climbs 70 Granted Orphan Drug 70 Considers Sale 70 Receives Fast Track 70 Updates Outlooks 70 Initiates Quarterly Dividend 70 Posts Quarterly 70 Posts Smaller 70 1Q Loss Narrows 70 Continues Winning Streak 70 Posts 1Q 70 Finalize Joint Venture 70 License Pact 70 Manufacturer Selects 70 Receives Regulatory 70 Inks Deal 70 Loss Shrinks 70 Motorola Invests 70 Issued Patent 70 ev3 logo 70 PRNewsFoto 70 Finalizes Contract 70 Movers roundup 70 Boosts Stake 70 Amends Merger Agreement 70 researches develops licenses 70 Files Countersuit Against 70 4Q Profit Jumps 70 Signs Definitive Merger Agreement 70 Other OTC USOG 70 novel proprietary KL4 70 Announces Acquisition 70 1Q Profit Surges 70 Activity Alert 70 Collaborators Publish 70 Patent Lawsuit Against 70 Platform Enables 70 Host Third Quarter 70 Genentech Wyeth Pharmaceuticals 70 SWOT Analysis www.companiesandmarkets.com adds 70 Announces Proposed 70 Seeks Injunction Against 70 Buyers Accumulating Shares 70 Awarded Contract Extension 70 Affirms Commitment 70 Presents Preclinical 70 Strengthens Relationship 70 2Q Loss Narrows 70 Reinforces Commitment 70 Profit Beats Expectations 70 Gets Favorable 70 Enlarges 70 Signs Definitive Agreement 70 Inc. www.micromet inc.com 70 Posts 3Q 70 Jointly Promote 70 Software Simplifies 70 Awarded Prestigious 70 Clarifies Status 70 Q4 Profit Drops 70 Realigns 70 Provides Updates 70 Q4 Adj 70 Resubmits 70 Directors Authorizes 70 Markettelegraph.com 70 Helps Launch 70 treat hyperproliferative disorders 70 widens Quick Facts 70 OTC BB NECO 70 BIOTECHNOLOGY SOURCE 70 SectorWatch.biz Issues MarketStats 70 Becomes Wholly Owned Subsidiary 70 Earns Certification 70 http:/www.Send2Press.com SOURCE 70 NASDAQ MNKD focuses 70 Becomes Sole 70 Makes Hostile Bid 70 Commenced Against 70 Investigates Proposed Acquisition 70 Forms Strategic 70 Abandons Plans 70 Announces Refinancing 70 Significantly Reduces 70 Releases Upgraded 70 Reach Settlement 70 Crofelemer budesonide foam 70 Announce Reseller Agreement 70 3M Completes Acquisition 70 Quarterly Loss Widens 70 Demonstrates Commitment 70 Shows Promise 70 Enters Into Collaboration 70 Kevin Matras Highlights 70 Posts 4Q Loss 70 Underscores Commitment 70 Signs Pact 70 Lowers Price 69 Schedules Fiscal 69 Technicals Showing Bearish 69 Approve Merger 69 Commences Tender Offer 69 Myriad logo BRACAnalysis 69 Sets Third Quarter 69 3Q Profit Rises 69 Trend Continues Down 69 Q2 Profit Drops 69 3Q Profit Surges 69 Plans Buyback 69 otcstockexchange.com 69 &Amp; 69 HOT STOCKS 69 Sentiment Snapshot 69 www.shamrockstocks.com About 69 Acquire Majority Stake 69 COMUNICADO DE 69 Reaffirms FY# Outlook 69 Acquire Controlling Interest 69 2Q Profit Surges 69 Webcast Presentations 69 Inks MOU 69 Significantly Improves 69 Expands Scientific Advisory 69 Host Second Quarter 69 Stock Upgraded 69 IIROC Resume 69 Announces Resumption 69 Summarizes 69 Announce Interoperability 69 Corporation NasdaqGS 69 Completes Redemption 69 4Q Profit Soars 69 Increases Commitment 69 Host Webcast 69 Q3 Profit Climbs 69 Settles Dispute With 69 Sells Remaining 69 Settle Dispute 69 Narrows 1Q 69 Announce Partnership 69 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 69 Submits Bid 69 Reaches Tentative Settlement 69 Increases Stake 69 Enable Next Generation 69 Announces Expiration 69 Announces Repurchase 69 Wins Lawsuit Against 69 Shareholders Approve Name 69 Expands Globally 69 Repositions 69 Backs FY# Outlook 69 Proposed Buyout 69 News Unternehmensnachrichten 69 Reaffirms Commitment 69 Webcast Second Quarter 69 3Q Profit Plunges 69 Finalizes Joint Venture 69 BullMarket.com Previews Earnings 69 Millenium Pharmaceuticals 69 Q2 Profit Decreases 69 Had Bearish Engulfing 69 OTCStockExchange.com Stock Alert 69 Successfully Completes Phase 69 Posts 3Q Profit 69 OKs Buyback 69 Expands Distribution 69 Syneron logo 69 AGREEMENTS SOURCE 69 Receives Coveted 69 Lowers Outlook 69 Resumes Coverage 69 Maintains Strong 69 Receives Conditional Approval 69 Hikes Dividend 69 WeissComm Partners +#-#-#-# 69 Announces Expansion 69 Proudly Announces 69 Sets Release Date 69 Announces Definitive Agreements 69 Announces Proposed Acquisition 69 Canaccord Genuity Maintains Buy 69 Expands Presence 69 Collaborators Present 69 Boosts Outlook 69 Declares Dividend Increase 69 Announces Ticker Symbol 69 Patent Infringement Lawsuit Against 69 Expands Relationship 69 Extends Offer 69 High Growth Forecasted 69 Issues Statement Regarding 69 Signs Long Term 69 Completes Private Placement 69 Announce Fiscal 69 TRADESHOW SOURCE 69 Announces Participation 69 Revolutionizes 69 Signs Option Agreement 69 Issues Guidance 69 Q2 Profit Climbs 69 Taps Lobbyist 69 Files Patent Infringement Suit 69 Announces Fiscal 69 Unveils Latest Version 69 Selects Trintech 69 Successfully Completes 69 Recent Trades 69 Reminds Shareholders 69 Given Outperform Rating 69 Files Revised 69 1Q Profit Doubles 69 Expects 4Q 69 Deliver Comprehensive 69 Inks Multi 69 -Pahuta 69 Executive Exercises Options 69 markets COLAZAL 69 Signs Definitive Agreements 69 Receives Accolades 69 ExxonMobil Fluor 69 Receives Funding 69 Lowers 4Q 69 Receives Deficiency Letter 69 Reports Narrower Loss 69 Achieves ISO #:# Certification [001] 69 Gets Favorable Ruling 69 Host Teleconference